Clinical Trial

Individualized Surgical Guidance in HCC-BDTT

Name: Individualized Surgical Guidance in HCC-BDTT — clinical trial record (NCT07483242)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

The Rboost causal model can identify patients who are most likely to benefit among HCC-BDTT patients. Adherence to the individualized recommendation improves survival. This data-driven tool offers vital support for precision surgical decision-making in this high-risk disease.

Trial Details

NCT Number	NCT07483242
Lead Sponsor	First Affiliated Hospital, Sun Yat-Sen University
Conditions	Hepatocellular Carcinoma (HCC)
Enrollment	151 participants
Start Date	2024-08-01
Primary Completion	2025-06-01 (estimated)
Study Completion	2025-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-19